French regulator ANSM has implemented a new system to speed up the authorization of clinical trials that offers two fast-track options for innovative new drugs and new trials of known substances.
Sponsors are invited to take part in the initial test run of the new system, which promises maximum processing times for trial applications of 40 days for innovative medicines (the...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?